Clinical Trial Update: A Phase II Study to Evaluate Safety and Efficacy of Combined Treatment With Ipilimumab and Intratumoral Interleukin-2 [Phase 2]

View source ↗

Summary

This update reports results from a Phase II study evaluating the safety and efficacy of combining ipilimumab with intratumoral interleukin-2 in patients with ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• Interleukin-2 (intratumoral) (interleukin-2)
• Yervoy (ipilimumab)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Malignant Melanoma | Phase 2 | Status: COMPLETED